4-butyrolactone has been researched along with dysidiolide in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 14 (87.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchard, JL; Boisclair, MD; Epstein, DM; Pal, K; Rudolph, J | 1 |
| Dodo, K; Hashimoto, Y; Shirai, R; Sugimoto, Y; Takahashi, M; Yamada, Y | 1 |
| Caillé, S; Chen, G; Piers, E | 1 |
| Demeke, D; Forsyth, CJ | 1 |
| Aoyagi, Y; Dodo, K; Hashimoto, Y; Shirai, R; Sugimoto, Y; Takahashi, M; Yamada, Y | 1 |
| Maichle-Mössmer, C; Maier, ME; Paczkowski, R | 1 |
| Hara, Y; Kajiwara, Y; Miyaoka, H; Yamada, Y | 1 |
| Jung, ME; Nishimura, N | 1 |
| Bhargava, A; Brohm, D; Lieb, F; Metzger, S; Müller, O; Philippe, N; Waldmann, H | 1 |
| Bhargava, A; Brohm, D; Lieb, F; Metzger, S; Müller, O; Waldmann, H | 1 |
| Kajiwara, Y; Miyaoka, H; Yamada, Y; Yamanishi, M | 1 |
| Basabe, P; Broughton, HB; Diez, D; García, N; Marcos, IS; Mollinedo, F; Moro, RF; Pedrero, AB; Sexmero, MJ; Urones, JG | 1 |
| Dodo, K; Shimazawa, R; Shirai, R; Suzuki, T | 1 |
| Mitome, H; Miyaoka, H; Yamanishi, M | 1 |
| Basabe, P; de la Iglesia-Vicente, J; Diez, D; Escola, MA; Marcos, IS; Mollinedo, F; Moro, RF; Sanz, F; Sierra, BG; Urones, JG | 1 |
| Kamada, Y; Moustafa, GA; Tanaka, T; Yoshimitsu, T | 1 |
16 other study(ies) available for 4-butyrolactone and dysidiolide
| Article | Year |
|---|---|
Dysidiolide and related gamma-hydroxy butenolide compounds as inhibitors of the protein tyrosine phosphatase, CDC25.
Topics: 4-Butyrolactone; cdc25 Phosphatases; Enzyme Inhibitors | 1999 |
Synthesis of a novel class of cdc25A inhibitors from vitamin D3.
Topics: 4-Butyrolactone; Antineoplastic Agents; cdc25 Phosphatases; Cholecalciferol; Enzyme Inhibitors; G1 Phase; HL-60 Cells; Humans | 2000 |
A formal total synthesis of the sesterterpenoid (+/-)-dysidiolide and approaches to the syntheses of (+/-)-6-epi-, (+/-)-15-epi-, and (+/-)-6,15-bisepidysidiolide.
Topics: 4-Butyrolactone; Enzyme Inhibitors; Models, Molecular; Molecular Conformation; Structure-Activity Relationship | 2000 |
Novel total synthesis of the anticancer natural product dysidiolide.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Enzyme Inhibitors; Porifera; Protein Tyrosine Phosphatases | 2000 |
Synthesis of the novel analogues of dysidiolide and their structure-activity relationship.
Topics: 4-Butyrolactone; cdc25 Phosphatases; Cell Cycle; Enzyme Inhibitors; Structure-Activity Relationship | 2000 |
A formal total synthesis of dysidiolide.
Topics: 4-Butyrolactone; cdc25 Phosphatases; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; X-Ray Diffraction | 2000 |
Total synthesis of natural dysidiolide.
Topics: 4-Butyrolactone; Animals; Magnetic Resonance Spectroscopy; Porifera | 2001 |
Enantioselective formal total synthesis of (-)-dysidiolide.
Topics: 4-Butyrolactone; Alkadienes; Alkenes; Esters; Molecular Conformation; Sesterterpenes; Terpenes | 2001 |
Solid-phase synthesis of dysidiolide-derived protein phosphatase inhibitors.
Topics: 4-Butyrolactone; cdc25 Phosphatases; Chemistry, Organic; Cross-Linking Reagents; Enzyme Inhibitors; Sesquiterpenes; Solutions | 2002 |
Natural products are biologically validated starting points in structural space for compound library development: solid-phase synthesis of dysidiolide-derived phosphatase inhibitors.
Topics: 4-Butyrolactone; Biological Products; cdc25 Phosphatases; Cell Survival; Enzyme Inhibitors; Oxidation-Reduction; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |
Total synthesis of cladocorans A and B: a structural revision.
Topics: 4-Butyrolactone; Animals; Anthozoa; Indicators and Reagents; Mediterranean Sea; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Stereoisomerism | 2003 |
Synthesis of bioactive sesterterpenolides from ent-halimic acid. 15-epi-ent-Cladocoran A and B.
Topics: 4-Butyrolactone; Antineoplastic Agents; Cell Division; Cell Line, Tumor; Humans; Inhibitory Concentration 50; Protein Tyrosine Phosphatases; Sesterterpenes; Stereoisomerism; Structure-Activity Relationship; Terpenes | 2003 |
Design and synthesis of dysidiolide analogs from vitamin D3: novel class of Cdc25A inhibitors.
Topics: 4-Butyrolactone; cdc25 Phosphatases; Cholecalciferol; Drug Design; Enzyme Inhibitors; Humans | 2004 |
PLA2 inhibitory activity of marine sesterterpenoids cladocorans, their diastereomers and analogues.
Topics: 4-Butyrolactone; Animals; Anthozoa; Bee Venoms; Bees; Indicators and Reagents; Magnetic Resonance Spectroscopy; Phosphodiesterase Inhibitors; Phospholipases A; Phospholipases A2; Stereoisomerism; Terpenes | 2006 |
Synthesis of novel antitumoural analogues of dysidiolide from ent-halimic acid.
Topics: 4-Butyrolactone; Aldehydes; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Hydroxylation; Ketones; Models, Molecular; Molecular Structure; Sesterterpenes; Stereoisomerism; Structure-Activity Relationship; Terpenes | 2007 |
Stereoconvergent route to chiral cyclohexenone building blocks: formal synthesis of (-)-dysidiolide.
Topics: 4-Butyrolactone; Cyclohexenes; Molecular Structure; Stereoisomerism | 2012 |